A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery

References

• American Academy of Ophthalmology Refractive Management/Intervention PanelPreferred Practice Pattern^® Guidelines. Refractive Errors and Refractive SurgerySan Francisco, CAAmerican Academy of Ophthalmology2013 Available from: www.aao.org/pppAccessed May 4, 2015
   Google Scholar
• NarooSACharmanWNChanges in posterior corneal curvature after photorefractive keratectomyJ Cataract Refract Surg20002687287810889434
   PubMed Web of Science ®Google Scholar
• DuppsWJWilsonSEBiomechanics and wound healing in the corneaExp Eye Res20068370972016720023
   PubMed Web of Science ®Google Scholar
• ShorttAJAllanBDEvansJRLaser-assisted in-situ keratomileusis (LASIK) versus photorefractive keratectomy (PRK) for myopiaCochrane Database Syst Rev20131CD00513523440799
   PubMed Web of Science ®Google Scholar
• LoewensteinALipshitzIVarssanoDLazarMComplications of excimer laser photorefractive keratectomy for myopiaJ Cataract Refract Surg199723117411769368160
   PubMed Web of Science ®Google Scholar
• AlioJLArtolaAClaramontePJAyalaMJSanchezSPComplications of photorefractive keratectomy for myopia: two year follow-up of 3000 casesJ Cataract Refract Surg1998246196269610444
   PubMed Web of Science ®Google Scholar
• Moller-PedersonTCavanaghHDPetrollWMJesterJVStromal wound healing explains refractive instability and haze development after photorefractive keratectomy: a 1-year confocal microscopic studyOphthalmology20001071235124510889092
   PubMed Web of Science ®Google Scholar
• DonnenfeldEDO’BrienTPSolomonRPerryHDSpeakerMGWittpennJInfectious keratitis after photorefractive keratectomyOphthalmology200311074374712689896
   PubMed Web of Science ®Google Scholar
• WroblewskiKJPasternakJFBowerKSInfectious keratitis after photorefractive keratectomy in the United States army and navyOphthalmology200611352052516488012
   PubMed Web of Science ®Google Scholar
• de RojasVLlovetFMartinezMInfectious keratitis in 18,651 laser surface ablation proceduresJ Cataract Refract Surg2011371822183121865006
   PubMed Web of Science ®Google Scholar
• VetrugnoMMainoAQuarantaGMCardiaLThe effect of early steroid treatment after PRK on clinical and refractive outcomesActa Ophthalmol Scand200179232711167281
   PubMedGoogle Scholar
• BaekSHChangJHChoiSYKimWJLeeJHThe effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomyJ Refract Surg1997136446529427202
   PubMed Web of Science ®Google Scholar
• ArasCOzdamarAAktuncRErcikanCThe effects of topical steroids on refractive outcome and corneal haze, thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameterOphthalmic Surg Lasers1998296216279715485
   PubMedGoogle Scholar
• O’BrartDPLohmannCPKlononsGThe effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy. A prospective, randomized observer-masked studyOphthalmology1994101156515747522315
   PubMed Web of Science ®Google Scholar
• McGheeCNDeanSDanesh-MeyerHLocally administered ocular corticosteroids: benefits and risksDrug Saf200225335511820911
   PubMed Web of Science ®Google Scholar
• BodorNLoftssonTWuWMMetabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonatePharm Res19929127512781448425
   PubMed Web of Science ®Google Scholar
• DruzgalaPWuWMBodorNOcular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyesCurr Eye Res1991109339371959381
   PubMed Web of Science ®Google Scholar
• ComstockTLDeCoryHHAdvances in corticosteroid therapy for ocular inflammation: loteprednol etabonateInt J Inflam2012201278962310.1155/2012/78962322536546
   PubMedGoogle Scholar
• ComstockTLPaternoMRSinghAErbTDavisESafety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgeryClin Ophthalmol2011517718621383946
   PubMedGoogle Scholar
• LaneSSHollandEJLoteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgeryJ Cataract Refract Surg20133916817323232255
   PubMed Web of Science ®Google Scholar
• The Loteprednol Etabonate Postoperative Study Group 2A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammationOphthalmology1998105178017869754192
   PubMed Web of Science ®Google Scholar
• ZhangQ-SWangXWangZ-HInfluence of lotemax eyedrops on intraocular pressure following excimer laser corneal refractive surgeryChin J Exp Ophthalmol2013316551554
   Google Scholar
• LiW-TLiHWeiJClinical study on the application of 5 g/L loteprednol etabonate ophthalmic suspension after LASIKInt J Ophthalmol201010917921793
   Google Scholar
• GaoD-HLiK-JLuHClinical observations on the effect of Lotemax on changes in intra-ocular pressure after LASEK [sic: LASIK]Int J Ophthalmol2010109806807
   Google Scholar
• WuJ-SZhongX-WZhangX-XA randomized controlled study on the application of 0.5% loteprednol etabonate eye drops after LASIK surgeryChin J Exp Ophthalmol2012307641645
   Google Scholar
• MifflinMDLeishmanLLChristiansenSMSikderSHsuMMoshirfarMUse of loteprednol for routine prophylaxis after photo-refractive keratectomyClin Ophthalmol2012665365922570546
   PubMedGoogle Scholar
• ThanathaneeOSriphonPAnutarapongpanOA randomized controlled trial comparing dexamethasone with loteprednol etabonate on postoperative photorefractive keratectomyJ Ocular Pharmacol Ther201531165168
   PubMed Web of Science ®Google Scholar
• HollandEJDjalilianARSandersonJPAttenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantationCornea2009281139114319770719
   PubMed Web of Science ®Google Scholar
• BartlettJDHorwitzBLaibovitzRHowesJFIntraocular pressure response to loteprednol etabonate in known steroid respondersJ Ocul Pharmacol199391571658345288
   PubMedGoogle Scholar
• CoffeyMJDeCoryHHLaneSSDevelopment of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic dropClin Ophthalmol2013729931223430378
   PubMedGoogle Scholar
• RajpalRKRoelLSiou-MermetRErbTEfficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgeryJ Cataract Refract Surg20133915816723218817
   PubMed Web of Science ®Google Scholar
• FongRLeitrizMSiou-MermetRErbTLoteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trialClin Ophthalmol201261113112422888209
   PubMedGoogle Scholar
• International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human UseICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6(R1)61996 Available from: http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/good-clinical-practice.htmlAccessed October 8, 2015
   Google Scholar
• PleyerUUrsellPGRamaPIntraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?Ophthalmol Ther201322557225135807
   PubMedGoogle Scholar
• WhiteEMMacyJIBatemanKMComstockTLComparison of the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitisCurr Med Res Opin20082428729618062846
   PubMed Web of Science ®Google Scholar
• ChenMGongLSunXA multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitisCurr Med Res Opin20122838539422256909
   PubMed Web of Science ®Google Scholar
• HollandEJBartlettJDPaternoMRUsnerDWComstockTLEffects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteersCornea200827505518245967
   PubMed Web of Science ®Google Scholar
• NovackGDHowesJCrockettSSherwoodMBChange in intraocular pressure during long-term use of loteprednol etabonateJ Glaucoma199872662699713785
   PubMed Web of Science ®Google Scholar
• Loteprednol Etabonate US Uveitis Study GroupControlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitisAm J Ophthalmol199912753754410334346
   PubMed Web of Science ®Google Scholar
• JungHHJiYSSungMSKimKKYoonKCLong-term outcome of treatment with topical corticosteroids for severe dry eye associated with Sjogren’s syndromeChonnam Med J201551263225914877
   PubMedGoogle Scholar
• AllanBDHassanHTopography-guided transepithelial photorefractive keratectomy for irregular astigmatism using a 213 nm solid-state laserJ Cataract Refract Surg2013399710423158680
   PubMed Web of Science ®Google Scholar
• HansenRSLyhneNGrauslundJGronbechKTVestergaardAHFour-year to seven-year outcomes of advanced surface ablation with excimer laser for high myopiaGraefes Arch Clin Exp Ophthalmol201525371027103325582070
   PubMed Web of Science ®Google Scholar
• DawsonDGGrossniklausHEMcCareyBEEdelhasuerHFBiomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman’s keratomileusis?J Refract Surg200824S90S9618269157
   PubMed Web of Science ®Google Scholar
• SiganosDSKatsanevakiVJPallikarisIGCorrelation of subepithelial haze and refractive regression 1 month after photorefractive keratectomy for myopiaJ Refract Surg19991533834210367577
   PubMed Web of Science ®Google Scholar
• SadighALFouladiRJHashemiHBeheshtnejadAHA comparison between Goldmann applanation tonometry and dynamic contour tonometry after photorefractive keratectomyGraefes Arch Clin Exp Ophthalmol201325160360822940796
   PubMed Web of Science ®Google Scholar
• AristeidouAPLabirisGKatsanosAFanariotisMFoudoulakisNCKozobolisVPComparison between Pascal dynamic contour tonometer and Goldmann applanation tonometer after different types of refractive surgeryGraefes Arch Clin Exp Ophthalmol2011249576777320577756
   PubMed Web of Science ®Google Scholar